BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Antengene Administers First Patient in US Clinical Study of ATG-017 for Advanced Solid Tumors with Nivolumab Combination

- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...

July 18, 2023 | News

Lonza Launches TheraPRO® CHO Media System

Lonza’s new cell culture media system is designed to optimize the production of therapeutic monoclonal antibodies The two-part production system i...

July 17, 2023 | News

Harbour BioMed's 2023 Interim Results: Positive Profit Alert Driven by Innovation

Based on the preliminary review of the Company's unaudited management accounts for the six months ended June 30, 2023, the total revenue is ex...

July 14, 2023 | News

Nona Biosciences and DualityBio Collaborate on Antibody Drug Conjugate (ADC): Business Update

Nona Biosciences entered into a collaboration agreement with DualityBio in 2022, pursuant to which Nona Biosciences granted the exclusive rights ...

July 14, 2023 | News

Kedrion's global portfolio expands to China to supply human Albumin

Kedrion joined forces with BPL in 2022 This is the first ever approval for a BPL product in China The China Albumin market is the world's largest ...

July 13, 2023 | News

Velico Medical begins clinical trial on Spray Dried Plasma

This first in-human clinical trial using Velico's spray drying system is taking place at Hoxworth Blood Center, Cincinnati, Ohio; Versiti Blood Center...

July 13, 2023 | News

Raya Therapeutic announces early-stage R&D collaboration with argenx

"We are delighted to be entering this early-stage R&D collaboration with argenx. argenx is one of the industry's most exciting companies, and their bel...

July 13, 2023 | News

Biosyngen's First-in-class Cell Therapy BRG01 Receives FDA Fast Track Designation

Fast Track Designation (FTD) aims to facilitate the development of drugs targeting severe or life-threatening diseases that have the potential to a...

July 12, 2023 | News

TCI Unveils VeCollal®: Biomimetic Collagen Mirroring Human Collagen, Validated by Belgian Clinical Study

In recent years, the growing awareness among consumers regarding environmental protection and health has driven the demand for vegan collagen. This growing...

July 12, 2023 | News

Putting Patients First: The Quest to Make Anticancer Cell Therapy Accessible to All

With the inauguration of a new state-of-the-art cell therapy lab in early 2022, BeiGene is looking to broaden collaboration and expand ...

July 12, 2023 | News

NK:IO Secures £1.6M Innovate UK Grant for Pioneering Cancer Therapy

Grant award of £1.6M supports program of development work with Cell and Gene Therapy Catapult NK:IO’s platform, based on pionee...

July 11, 2023 | News

VitaDAO Launches VITA-FAST Tokens, Revolutionizing Governance in Longevity Research

The VITA-FAST tokens, which allow holders to make decisions on IP licensing, set experiment priorities, and govern research on autophagy, have been met wit...

July 11, 2023 | News

GeneQuantum Healthcare and Aimed Bio collaborate to develop 5 innovative ADC drugs

Since April of last year, GeneQuantum and Aimed Bio have been collaborating on the joint development of a FGFR3-targeting ADC named GQ1011/AMB302. The prog...

July 07, 2023 | News

ENPICOM secures extended financing to continue driving breakthroughs in therapeutic discovery

ENPICOM, an innovative bioinformatics software engineering company, has successfully secured further financial backing from its current investors BOP Capit...

July 07, 2023 | News

Stay Connected